# The Cancer of the Pancreas Screening-5 CAPS5)Study

Source: https://onco.cc/trials/nct02000089/  
OnCo record `nct02000089` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial in pancreatic cancer, run by Johns Hopkins University, now recruiting.

## Summary

The Cancer of the Pancreas Screening-5 CAPS5)Study is a phase 3, interventional study registered as NCT02000089 by Johns Hopkins University, with a registry enrolment figure of 9000 participants, started 2014-01-06 and due to reach its primary completion in 2028-12. Interventions recorded: Secretin; MRI; Tumor marker gene test with CA19-9. Conditions listed: Pancreas Cancer; Peutz-Jeghers Syndrome (PJS); Gene Mutation; Germline Mutation Carrier; Lynch Syndrome. Primary outcome: Evaluate pancreatic juice for early cancer markers.. Pancreatic eligibility wording from the registry: "* Hereditary Pancreatitis or". Sites: United States. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Also known as: CAPS5
- Tags: ctgov-ingest; pancreatic-deep-dive
- Registry id: NCT02000089
- Phase: 3
- Setting: The Cancer of the Pancreas Screening-5 CAPS5)Study
- Sponsor: Johns Hopkins University
- Enrolled: 9000

## Sources

- ClinicalTrials.gov NCT02000089: https://clinicaltrials.gov/study/NCT02000089

## Connected records

- cancers: [Pancreatic ductal adenocarcinoma](https://onco.cc/cancers/pancreatic/)
- terms: [Pancreatic cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/pancreatic-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct02000089.json